Drug Trial Radar · NCT03134196
Zoster Eye Disease Study
Last checked: Nov 19, 2026Latest source record: Mar 7, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
527
Actual
Start
Aug 23, 2017
Primary completion
Dec 31, 2023
Study completion Jul 22, 2024
Sponsor
- Lead sponsor
- NYU Langone HealthAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Eye Institute (NEI); National Institutes of Health (NIH)
- First posted
- Apr 28, 2017
Design
- Study type
- Interventional
- Phase
- Phase 4
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a multi-center, randomized, double-masked, placebo-controlled clinical trial of suppressive valacyclovir for one year in immunocompetent study participants with an episode of dendriform epithelial keratitis, stromal keratitis, endothelial keratitis, and/or iritis due to Herpes Zoster Ophthalmicus (HZO) in the year prior to enrollment.
Conditions
- Herpes Zoster Ophthalmicus
Interventions
Masked PlaceboDrug
Oral Placebo
Masked Oral ValacyclovirDrug
Oral Valacyclovir 1000 mg/day
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants With the First Occurrence of New or Worsening Stromal Keratitis Without Ulceration (SK), Endothelial Keratitis (EK), Iritis (IR), Dendriform Epithelial Keratitis (DEK), or Stromal Keratitis With Ulceration (SKU)Time frame: Month 12
Locations
78 sites in 2 countries. Site status is shown where the registry gives one.
University of Alabama at Birmingham
Birmingham, Alabama
Mayo Clinic - Arizona
Scottsdale, Arizona
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Scripps Clinic
La Jolla, California
Loma Linda University Eye Institute
Loma Linda, California
Jules Stein Eye Clinic - UCLA
Los Angeles, California
Byers Eye Institute at Stanford University
Palo Alto, California
UCSF- Francis I. Proctor Foundation
San Francisco, California
Pacific Eye Surgeons, Inc.
San Luis Obispo, California
University of Colorado
Aurora, Colorado
Colorado Cornea Consultants P.C.
Littleton, Colorado
Medstar Georgetown University Hospital
Washington D.C., District of Columbia
Delray Eye Associates, PA
Delray Beach, Florida
University of Florida
Gainesville, Florida
Florida Eye Specialists
Jacksonville, Florida
University of Miami - Bascom Palmer Eye Institute
Miami, Florida
Eye Consultants of Atlanta, PC
Atlanta, Georgia
University of Illinois
Chicago, Illinois
NorthShore University Health System
Glenview, Illinois
Case Western Reserve University
Cleveland, Indiana
Indiana University - Glick Eye Institute
Indianapolis, Indiana
University of Kansas Medical Center
Prairie Village, Kansas
University of Kentucky
Lexington, Kentucky
LSU Health Science Center
New Orleans, Louisiana
Shreveport Eye Clinic
Shreveport, Louisiana
University of Maryland
Baltimore, Maryland
The Krieger Eye Institute
Baltimore, Maryland
Wilmer Eye Institute John Hopkins
Bethesda, Maryland
Crossroads Eye Physician
Owings Mills, Maryland
Tufts Medical Center
Boston, Massachusetts
Massachusetts Eye and Ear Infirmary
Boston, Massachusetts
Boston Medical Center
Boston, Massachusetts
Lahey Medical Center
Peabody, Massachusetts
Eye Health Services
Weymouth, Massachusetts
University of Michigan
Ann Arbor, Michigan
Verdier Eye Center
Grand Rapids, Michigan
Northwest Eye Clinic
Golden Valley, Minnesota
Jennifer Burdick
Minnetonka, Minnesota
Mayo Clinic
Rochester, Minnesota
Washington University Opthalmology
St Louis, Missouri
Showing 40 of 78 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.